ArticleAntiviral research2023

The antiviral effects of a MEK1/2 inhibitor promote tumor regression in a preclinical model of human papillomavirus infection-induced tumorigenesis.

Adrian J Luna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.